For patients who experienced an early BC event despite having PRLR-low tumors, PRLR was a negative modulator of TFs from the bZIP pathway and general transcription (Figure 4C), and it also suppressed the Notch signaling pathway in the PRLR-high group without early events (Figure 4D). The gene discussed is PRLR; the disease is breast cancer.